Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Boosts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in Azenta, Inc. (NASDAQ:AZTAFree Report) by 8.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 5,100 shares of the company’s stock after acquiring an additional 408 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Azenta were worth $256,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Thrivent Financial for Lutherans grew its position in shares of Azenta by 0.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 19,855 shares of the company’s stock worth $851,000 after buying an additional 183 shares during the period. Huntington National Bank grew its position in Azenta by 35.3% during the 2nd quarter. Huntington National Bank now owns 782 shares of the company’s stock valued at $37,000 after purchasing an additional 204 shares during the last quarter. IMA Wealth Inc. grew its position in Azenta by 0.6% during the 2nd quarter. IMA Wealth Inc. now owns 39,535 shares of the company’s stock valued at $1,845,000 after purchasing an additional 232 shares during the last quarter. Neuberger Berman Group LLC grew its position in Azenta by 1.6% during the 4th quarter. Neuberger Berman Group LLC now owns 18,356 shares of the company’s stock valued at $1,069,000 after purchasing an additional 287 shares during the last quarter. Finally, Signaturefd LLC grew its position in Azenta by 25.7% during the 2nd quarter. Signaturefd LLC now owns 1,418 shares of the company’s stock valued at $66,000 after purchasing an additional 290 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Stock Performance

AZTA opened at $65.05 on Thursday. The stock has a market capitalization of $3.62 billion, a P/E ratio of -361.37 and a beta of 1.56. The company’s 50-day simple moving average is $63.62 and its two-hundred day simple moving average is $55.60. Azenta, Inc. has a 52-week low of $36.01 and a 52-week high of $69.16.

Azenta (NASDAQ:AZTAGet Free Report) last posted its earnings results on Monday, November 13th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.12. Azenta had a negative net margin of 2.14% and a positive return on equity of 0.75%. The business had revenue of $165.95 million for the quarter, compared to analysts’ expectations of $163.91 million. During the same quarter in the prior year, the business earned $0.16 EPS. The business’s revenue for the quarter was up 25.0% compared to the same quarter last year. Research analysts forecast that Azenta, Inc. will post 0.39 EPS for the current fiscal year.

Analysts Set New Price Targets

AZTA has been the topic of several recent analyst reports. B. Riley increased their price objective on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Needham & Company LLC increased their price objective on shares of Azenta from $68.00 to $76.00 and gave the company a “buy” rating in a research report on Thursday, January 18th. Finally, Stephens reissued an “equal weight” rating and set a $55.00 price objective on shares of Azenta in a research report on Tuesday, November 14th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $70.00.

Check Out Our Latest Research Report on Azenta

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.